PubMed:23952588 / 1278-1401
Annnotations
LitCoin-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T17 | 0-123 | Sentence | denotes | The three significant predictors of dyskinesia were duration of levodopa therapy, onset age, and total daily levodopa dose. |
LitCoin-entities
Id | Subject | Object | Predicate | Lexical cue | db_id |
---|---|---|---|---|---|
9348 | 36-46 | DiseaseOrPhenotypicFeature | denotes | dyskinesia | MESH:D004409 |
9349 | 64-72 | ChemicalEntity | denotes | levodopa | MESH:D007980 |
9350 | 109-117 | ChemicalEntity | denotes | levodopa | MESH:D007980 |
LitCoin-GeneOrGeneProduct-v0
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 97-102 | GeneOrGeneProduct | denotes | total |
LitCoin-Disease-MeSH
Id | Subject | Object | Predicate | Lexical cue | originalLabel |
---|---|---|---|---|---|
T16 | 36-46 | DiseaseOrPhenotypicFeature | denotes | dyskinesia | D020820 |
LitCoin-MeSH-Disease-2
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T16 | 36-46 | DiseaseOrPhenotypicFeature | denotes | dyskinesia | D020820 |
LitCoin-MONDO_bioort2019
Id | Subject | Object | Predicate | Lexical cue | #label |
---|---|---|---|---|---|
T14 | 36-46 | DiseaseOrPhenotypicFeature | denotes | dyskinesia | D020820 |
LitCoin-Chemical-MeSH-CHEBI
Id | Subject | Object | Predicate | Lexical cue | ID: |
---|---|---|---|---|---|
T8 | 64-72 | ChemicalEntity | denotes | levodopa | http://purl.obolibrary.org/obo/CHEBI_15765 |
T9 | 109-117 | ChemicalEntity | denotes | levodopa | http://purl.obolibrary.org/obo/CHEBI_15765 |
LitCoin-training-merged
Id | Subject | Object | Predicate | Lexical cue | #label | ID: |
---|---|---|---|---|---|---|
T9 | 109-117 | ChemicalEntity | denotes | levodopa | http://purl.obolibrary.org/obo/CHEBI_15765 | |
T8 | 64-72 | ChemicalEntity | denotes | levodopa | http://purl.obolibrary.org/obo/CHEBI_15765 | |
T14 | 36-46 | DiseaseOrPhenotypicFeature | denotes | dyskinesia | D020820 |